Plasma cathepsin s and cystatin c levels and risk of abdominal aortic aneurysm: A randomized population-based study

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Lv, Bing Jie ^a,b   Lindholt, Jes S ^c   Cheng, Xiang ^a   Wang, Jing ^b   Shi, Guo Ping ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c VIBORG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN S; CYSTATIN C;

ABDOMINAL AORTA ANEURYSM; AGED; ANKLE BRACHIAL INDEX; ARTERY DIAMETER; ARTICLE; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SCREENING TEST;

AGED; AORTIC ANEURYSM, ABDOMINAL; BLOOD PRESSURE; CATHEPSINS; COHORT STUDIES; CYSTATIN C; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; MALE; RISK FACTORS; SMOKING;

EID: 84864259637     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041813     Document Type: Article

References (35)

1. Satta J, Laurila A, Pääkkö P, Haukipuro K, Sormunen R, et al. (1998) Chronic inflammation and elastin degradation in abdominal aortic aneurysm disease: an immunohistochemical and electron microscopic study. Eur J Vasc Endovasc Surg 15: 313-319.
2. Lindholt JS, Heickendorff L, Henneberg EW, Fasting H, (1997) Serum-elastin-peptides as a predictor of expansion of small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 14: 12-16.
3. Lindholt JS, Ashton HA, Heickendorff L, Scott RA, (2001) Serum elastin peptides in the preoperative evaluation of abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 22: 546-550.
4. Abdul-Hussien H, Soekhoe RG, Weber E, von der Thüsen JH, Kleemann R, et al. (2007) Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases. Am J Pathol 170: 809-817.
5. Treska V, Topolcan O, (2000) Plasma and tissue levels of collagen types I and III markers in patients with abdominal aortic aneurysms. Int Angiol 19: 64-68.
6. Satta J, Haukipuro K, Kairaluoma MI, Juvonen T, (1997) Aminoterminal propeptide of type III procollagen in the follow-up of patients with abdominal aortic aneurysms. J Vasc Surg 25: 909-915.
7. Lindholt JS, Heickendorff L, Vammen S, Fasting H, Henneberg EW, (2001) Five-year results of elastin and collagen markers as predictive tools in the management of small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 21: 235-240.
8. Chapman HA, Riese RJ, Shi GP, (1997) Emerging roles for cysteine proteases in human biology. Annu Rev Physiol 59: 63-88.
9. Liu J, Sukhova GK, Yang JT, Sun J, Ma L, et al. (2006) Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells. Atherosclerosis 184: 302-311.
10. Shi GP, Sukhova GK, Grubb A, Ducharme A, Rhode LH, et al. (1999) Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 104: 1191-1197.
11. Abisi S, Burnand KG, Waltham M, Humphries J, Taylor PR, et al. (2007) Cysteine protease activity in the wall of abdominal aortic aneurysms. J Vasc Surg 46: 1260-1266.
12. Sun J, Sukhova GK, Zhang J, Chen H, Sjöberg S, et al. (2011) Cathepsin L activity is essential to elastase perfusion-induced abdominal aortic aneurysms in mice. Arterioscler Thromb Vasc Biol 31: 2500-2508.
13. Sun J, Sukhova GK, Zhang J, Chen H, Sjöberg S, et al. (2012) Cathepsin K deficiency reduces elastase perfusion-induced abdominal aortic aneurysms in mice. Arterioscler Thromb Vasc Biol 32: 15-23.
14. Schulte S, Sun J, Libby P, Macfarlane L, Sun C, et al. (2010) Cystatin C deficiency promotes inflammation in angiotensin II-induced abdominal aortic aneurisms in atherosclerotic mice. Am J Pathol 177: 456-463.
15. Williams IM, Hughes OD, Townsend E, Winter RK, Lewis MH, (1996) Prevalence of abdominal aortic aneurysm in a hypertensive population. Ann R Coll Surg Engl 78: 501-504.
16. Shiraya S, Miwa K, Aoki M, Miyake T, Oishi M, et al. (2006) Hypertension accelerated experimental abdominal aortic aneurysm through upregulation of nuclear factor kappaB and Ets. Hypertension 48: 628-636.
17. Eriksson P, Jones KG, Brown LC, Greenhalgh RM, Hamsten A, et al. (2004) Genetic approach to the role of cysteine proteases in the expansion of abdominal aortic aneurysms. Br J Surg 91: 86-89.
18. Bergoeing MP, Arif B, Hackmann AE, Ennis TL, Thompson RW, et al. (2007) Cigarette smoking increases aortic dilatation without affecting matrix metalloproteinase-9 and -12 expression in a modified mouse model of aneurysm formation. J Vasc Surg 45: 1217-1227.
19. Ridker PM, Rifai N, Clearfield M, Downs JR, Weis SE, et al. (2001) Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 344: 1959-1965.
20. Steinmetz EF, Buckley C, Shames ML, Ennis TL, Vanvickle-Chavez SJ, et al. (2005) Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice. Ann Surg 241: 92-101.
21. Zhang Y, Naggar JC, Welzig CM, Beasley D, Moulton KS, et al. (2009) Simvastatin inhibits angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-knockout mice: possible role of ERK. Arterioscler Thromb Vasc Biol 29: 1764-1771.
22. Shiraya S, Miyake T, Aoki M, Yoshikazu F, Ohgi S, et al. (2009) Inhibition of development of experimental aortic abdominal aneurysm in rat model by atorvastatin through inhibition of macrophage migration. Atherosclerosis 202: 34-40.
23. Hurks R, Hoefer IE, Vink A, Pasterkamp G, Schoneveld A, et al. (2010) Different effects of commonly prescribed statins on abdominal aortic aneurysm wall biology. Eur J Vasc Endovasc Surg 39: 569-576.
24. Grøndal N, Søgaard R, Henneberg EW, Lindholt JS, (2010) The Viborg Vascular (VIVA) screening trial of 65-74 year old men in the central region of Denmark: study protocol. Trials 11: 67.
25. Joensen JB, Juul S, Abrahamsen J, Henneberg EW, Lindholt JS, (2008) Doppler ultrasound compared with strain gauge for measurement of systolic ankle blood pressure. Angiology 59: 296-300.
26. Grøndal N, Bramsen MB, Thomsen MD, Rasmussen CB, Lindholt JS, (2012) The cardiac cycle is a major contributor to variability in size measurements of abdominal aortic aneurysms by ultrasound. Eur J Vasc Endovasc Surg 43: 30-33.
27. Shi GP, Munger JS, Meara JP, Rich DH, Chapman HA, (1992) Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. J Biol Chem 267: 7258-7262.
28. Taleb S, Cancello R, Clément K, Lacasa D, (2006) Cathepsin s promotes human preadipocyte differentiation: possible involvement of fibronectin degradation. Endocrinology 147: 4950-4959.
29. Wang B, Sun J, Kitamoto S, Yang M, Grubb A, et al. (2006) Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors. J Biol Chem 281: 6020-6029.
30. Yamashita A, Noma T, Nakazawa A, Saito S, Fujioka K, et al. (2001) Enhanced expression of matrix metalloproteinase-9 in abdominal aortic aneurysms. World J Surg 25: 259-265.
31. Crowther M, Goodall S, Jones JL, Bell PR, Thompson MM, (2000) Localization of matrix metalloproteinase 2 within the aneurysmal and normal aortic wall. Br J Surg 87: 1391-1400.
32. Shi GP, Villadangos JA, Dranoff G, Small C, Gu L, et al. (1999) Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity 10: 197-206.
33. Sukhova GK, Zhang Y, Pan JH, Wada Y, Yamamoto T, et al. (2003) Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J Clin Invest 111: 897-906.
34. Liu J, Ma L, Yang J, Ren A, Sun Z, et al. (2006) Increased serum cathepsin S in patients with atherosclerosis and diabetes. Atherosclerosis 186: 411-419.
35. Lindholt JS, Erlandsen EJ, Henneberg EW, (2001) Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms. Br J Surg 88: 1472-1475.